Brock Rogers Surgical Inc.
This article was originally published in Start Up
Executive Summary
Computer-Guided Surgery. Brock Rogers is developing a unique set of laparoscopic instruments that combine a robotic telemanipulator and artificial intelligence to increase a surgeon's dexterity and transmit a sense of touch to the surgeon's hand. The company will develop tools for minimally-invasive fundoplication, cholecystectomy, colectomy, and coronary artery bypass grafting, among other procedures.
You may also be interested in...
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.